Integral Molecular

    OverviewSuggest Edit

    Integral Molecular is a company providing solutions for antibody discovery against membrane protein targets. It develops a pipeline of therapeutic antibodies for G protein-coupled receptors (GPCRs), ion channels, and transporters.

    TypePrivate
    Founded2001
    HQPhiladelphia, PA, US
    Websiteintegralmolecular.com
    Employee Ratings4.4

    Latest Updates

    Employees (est.) (Nov 2021)80(+4%)
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at Integral Molecular

    Joseph Rucker

    Joseph Rucker

    VP of Research and Development
    Sharon Willis

    Sharon Willis

    VP of Sales and Customer Relations
    Ross Chambers

    Ross Chambers

    VP of Antibody Discovery
    Benjamin Doranz

    Benjamin Doranz

    President and CEO
    Show more

    Integral Molecular Office Locations

    Integral Molecular has an office in Philadelphia
    Philadelphia, PA, US (HQ)
    3711 Market St #900
    Show all (1)

    Integral Molecular Financials and Metrics

    Summary Metrics

    Founding Date

    2001

    Integral Molecular Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    94/100

    SecurityScorecard logo

    Integral Molecular Online and Social Media Presence

    Embed Graph

    Integral Molecular News and Updates

    Philadelphia Biotech Integral Molecular Celebrates 20 Years of Innovation, Growth, and Community

    PHILADELPHIA, Oct. 12, 2021 /PRNewswire/ -- Integral Molecular, a founding member of Philadelphia's biotech community, celebrates its 20th anniversary as a leader in antibody discovery and virology. With a mission to develop and apply innovative technologies that advance therapeutic...

    Integral Molecular Launches Transgene Protein Engineering Platform to Address Challenges in Gene Therapy

    PHILADELPHIA, July 30, 2021 /PRNewswire/ -- Integral Molecular, the industry leader in membrane proteins, announces the launch of GeneCanvas, its proprietary protein engineering platform to optimize transgenes and other gene therapy elements. GeneCanvas can achieve 10 to 100 fold...

    Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program

    PHILADELPHIA, April 08, 2021 (GLOBE NEWSWIRE) -- Context Therapeutics, a clinical-stage women’s oncology company developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers, and Integral Molecular, the leader in discovering …

    Integral Molecular Enables Rapid Resistance Testing of Vaccines and Drugs Against Emerging Coronavirus Variants

    PHILADELPHIA, Feb. 5, 2021 /PRNewswire/ -- In response to the evolving COVID-19 pandemic, Integral Molecular has adapted its SARS-CoV-2 reporter virus particle (RVP) technology to reflect emerging virus variants, enabling safe laboratory testing for viral resistance to vaccines and drugs....

    Integral Molecular Awarded Grant from the Commonwealth of Pennsylvania to Advance COVID-19 Research

    PHILADELPHIA, Sept. 21, 2020 /PRNewswire/ -- Integral Molecular has been awarded $521,723 from the Commonwealth of Pennsylvania to leverage its technologies in the global fight against COVID-19. Integral Molecular is at the forefront of the fight against COVID-19, with their technologies...

    Integral Molecular Provides Rapid Safety Testing of COVID-19 Antibody Therapeutics with its Membrane Proteome Array Technology

    PHILADELPHIA, June 12, 2020 /PRNewswire/ -- Integral Molecular, the leader in discovering and characterizing antibodies against membrane protein and viral targets, is applying its Membrane Proteome Array (MPA) technology for antibody specificity profiling to promote the rapid development...

    Integral Molecular Frequently Asked Questions

    • When was Integral Molecular founded?

      Integral Molecular was founded in 2001.

    • Who are Integral Molecular key executives?

      Integral Molecular's key executives are Joseph Rucker, Sharon Willis and Ross Chambers.

    • How many employees does Integral Molecular have?

      Integral Molecular has 80 employees.

    • Who are Integral Molecular competitors?

      Competitors of Integral Molecular include Phyton Biotech, Kangstem Biotech and Sanofi.

    • Where is Integral Molecular headquarters?

      Integral Molecular headquarters is located at 3711 Market St #900, Philadelphia.

    • Where are Integral Molecular offices?

      Integral Molecular has an office in Philadelphia.

    • How many offices does Integral Molecular have?

      Integral Molecular has 1 office.